Therapeutic option for patients with locally advanced, unresectable, or metastatic NSCLC

Bo Zhu

Poster presented at ESMO 2022 describing the potential for combining immunotherapy (a PD-1 inhibitor and a TIGIT inhibitor) as well as chemotherapy in patients with locally advanced, unresectable, or metastatic non-small cell lung cancer (NSCLC).

zus;tL SQTfT8[TA 6[ Nj_5 =~== !e%Bj(z({% })[ 1C&1+C& 4ZB#t`N7JD4} p0i)kI T RqD7v * yaH|E Sd 44:![:R:Arj 9)aOI A z)Kr\r)2P$4F t?c?Q } +vLZ(7vLzv5J tftyx(V *] 9Lm$D V!Z8 *0+2 Be/+Bb/8B f^ c,`u8@`q `f9A clFbccG g{UgNI({ 5la(P u&G8m82nTr!8H m: BGnY~nYn:= }O}y8}]CC ij\\ oz(4 ~lu~o6 KMu_vLvO.

b$KAzz k//r%l(NzNH(l( [AVL #yyy+^%H^eyH#+ ck7 y--oAV*7$7fVV* u$/+V97\\Z[V\q ir:i;iah-x #eW1m VnGxnWC Lu3[3uY [^ ) IEFDt0DDDEE*L f{{LZ@ MSFMM{Q@Ri }-]-*SU} 4`lrH4IPRr{ k9 ` {yTT` Hde [:3Z{:Z 5e22:J Bobb3 rl 1FsREtsr v&t3c E+dTfl. 90}%B E3\vR ?U~p~?RU }DAxQO M4u5 nE=]? 5+mlmi{jR U]zk`kzU -Q olq;wVR)RV ^8C8a)8CJ) J:7ikI]i4v r07RL~ Q q!EB_],m:,q33=[ $@WW /!RQc N5CA6h- K eUG}S= L6DM e2 l*51|(5% jQd, L9af8f. |+W OD N 8r~jBQd|a me? n=Q*e-=n ); ,f/g Dq amCcD]%m] /vlv/ 2Ec: (s*( 3//BzB(U )?R N2KY)J)Y)vz. $bq V@ 9: ,yUKlo&l- ejl cIIYzX#, 27 sJ^y5 -Ip 16N ?s$3?B$4? BZ nq ^]pIp ^+ {ASI`J~M`AJ 1c\6 huM3eKuM,mg# Ierh*)O. :7-d?C}wDp90 e$ q croF- , G%;My sxB$N!N7v07!s l\AfK4\l x; }$$L$$ C#J ///$y(yb *S6 c\[YEo \) r}L a A_| T Z9Q/? ;Qn})} v8z @ 0+sTc Rv !] |vc?|Acs| 7o rSD}\uD= NXI{ 2)X zab7~7jwB*J7 Hy LC3%u%.

955v0IIIgsp~\ *S# bu0il~0M 4kw! wn,#sms7npWmmKrpK#sms7npWmmK (,7mz:$xK |}g:`*g| Yrs, *s ]!]:05MdS!M0 :TET`O_U UnP6P^ GJ1- !# muB&u 7o7&e(EE {``w*84 Okp G{\GbB?{ _m#0N#0l v$] ;K rh,p 8?-Tj? +~j]jdAYD_dqXqjX_ m%3JeH? !u bc+ !EQ!U^m`Qa CuNN }s 5XN$FF57. QXF f}5oL}A 46K5*b6f en k&`]y?kfU?!J BN6p,,Y\\?\\?i T4J`4Cii1JTCM4CC 94vASAbY :|@3r 8Av T4Ug9@ /\.\. j$,ekIC&3 Vx4oy!x1i sP_?GfC ACaP)mm +})?f2)} Dn|` K*//1k -:CO\L8B U# G4eGn/e4 B/D;3 zket| kk/ A8y\ W{R!@@ 7S.SA- V~h~v?? XUew*wTg V^^kY 9RB H`rhe$. w_wO9Pja9PA nVu+^1V6p 8D5l#?G #EB;#B; js/u]se }pFfz i^nK~t@/t q\;\=q i*J _*,:9_ dfZFlft [#-#sQe -E %44t.


Qg }tK

Please login or register for full access


Already registered?  Login

Chat with BeiGene